-
Gilead honors Camber parent company Hetero Drugs
PISCATAWAY, N.J. — Camber Pharmaceuticals announced Wednesday that its parent company, Hetero Drugs, has been recognized by Gilead Sciences for its work providing access to hepatitis C drugs for patients worldwide. Hetero markets sofosbuvir as Sofovir and ledipasvir-sofosbuvir as Ledifos in India and will eventually reach some 91 countries. The two drugs are better known in the United States and as Sovaldi and Harvoni.In India, an estimated 12 million to 18 million patients are infected with hepatitis C.Specialty Focused: DSN interviews Walgreens specialty pharmacy group VP
The significant role that specialty pharmacies play in specialty care — from ensuring patients have access to their specific disease state treatment to delivering necessary training and other services around their medication — is something Walgreens Specialty Pharmacy knows well.